Navigation Links
Sleeping pills reversly push to vegitative state

Zolpidem is usually used to treat insomnia. The effects of zolpidem on three patients were studied for a period of six months by South African researchers//. Neurological rehabilitation experts reveal that they are in a condition where keeping eyes open, awake but unaware of the surroundings, no interaction and responses, having signs of movement, sleep and breathing called vegetative state.

Zolpidem was given to the patients every morning.

An improvement was seen within 20 minutes of taking the drug, where out of the three patients (A,B,C), patient A was able to speak and reply to questions, patient B with the same changes and even catches a basketball whereas patient C after constant screaming was able to watch TV and give responses.

Dr Clauss, a co-worker said drugs like Zolpidem activate receptors in nerve cells in the brain for GABA.

This drug reshapes the damaged receptors and triggers nerve cell activity.

Mike Barnes, professor of neurological rehabilitation at the Hunters Moor centre in Newcastle, said it was possible that the patients had not had ‘true’ PVS means the patient should not wake up and respond.

But if they was no PVS, it would be a remarkable finding, and certainly worth further research.


'"/>




Page: 1

Related medicine news :

1. Sleeping sickness - a silent killer
2. Help For Kids With Difficulty In Sleeping
3. Sleeping Less May be related to Weight Gain
4. Sleeping Boy Does A Rip Van Winkle
5. With New Drug To Fight Against Sleeping, Your Increment Is Not Far Away
6. Uganda Reports Failure To Contain Sleeping Sickness
7. Fluorescent markers to distinguish Trypanosoma brucei strains causing Sleeping Sickness
8. Sleeping Is No Mean Art … It Is A Privilege Denied To Many
9. Toddlers Have Respiratory Trouble When Sleeping With Their Face Up
10. Sleeping disorder risk factor for heart attacks
11. Newer Generation Sleeping Pills Lack Superior Performance
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... , ... Hamlin Dental Group, multi-location dental office in North Hollywood , ... are safe and effective options, and can be used alone or in conjunction with ... of care. , Dr. Hamid Reza of Hamlin Dental Group offers other treatments as ...
(Date:3/29/2017)... ... ... has helped over 1.5 million SharePoint users learn the content management system faster and ... for SharePoint was at the farm level. Enterprises using SharePoint Online in Office 365 ... recently released a modified version of the Help System, VisualSP for Site Collections, which ...
(Date:3/28/2017)... ... March 28, 2017 , ... Greenfield Advisors is expanding ... extensive knowledge of appraisals, property values, ad valorem taxation, and government policy to ... for more than 40 years. , “Ruel is a great addition to the ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... Wallingford, CT (PRWEB) , ... March 28, 2017 ... ... hemostatic devices, announces today that the University of Pittsburgh Medical Center (UPMC) will ... Central and Western Pennsylvania. , The program, developed in association with efforts by ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ - ... service medical device development firm, announced today that it ... Toronto -based medical device industrial design and productization ... companies throughout North America with ... device talent spanning the design, engineering, regulatory, and manufacturing ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, 2017 ... Israel . This new business entity, Emosis Ltd, ... dedicated to research and development of novel assays complementing the mother ... when relevant, locally support commercialization and sales development of Emosis kits. ... This strategic move ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: